Hydrodistilled oils of the fresh aerial parts of Mentha suaveolens Ehrh. cultivated in Egypt were prepared from samples collected along the four seasons. The percentage yields of these essential oils were 0.50%, 0.52%, 0.60%, and 0.47% of the dry weight for winter, spring, summer, and autumn samples. GC/MS analyses of all samples revealed a qualitative and quantitative variability in the oil composition. The total number of compounds identifi ed was 46 among which 15 were common in all samples. The oxygenated compounds constituted about 45%, 46%, 63%, and 44% of the total composition of the oils for winter, spring, summer, and autumn samples, respectively. Carvone was the major constituent in spring, summer, and autumn samples (about 31%, 56%, and 35%, respectively), while limonene (ca. 26%) was the major constituent of the winter sample followed by carvone (ca. 25%). The essential oil of the highest yield (full-fl owering summer sample), with the highest oxygenated constituents and carvone contents, was screened for certain biological activities. It exhibited analgesic and acute anti-infl ammatory activities (75% and 82% relative to indomethacin). It also showed a potent in vivo antioxidant activity (96% relative to vitamin E). In addition, it exerted moderate cytotoxic, hepatoprotective, and in vitro antioxidant activities. Moreover, the oil had a potent antifungal activity against Candida albicans (MIC = 4 μg/ml), Saccharomyces cerevisiae (MIC = 5.2 μg/ml), and Aspergillus niger (MIC = 6.8 μg/ml).
Introduction
The genus Mentha of the Lamiaceae family is represented by about 19 species and 13 natural hybrids. Mentha suaveolens Ehrh. is native to Africa, Temperate Asia, and Europe (Abbaszadeh et al., 2009) .
Polymorphism has particularly been observed in hybrid populations of Mentha species which conserves novel genotypes. Studies of the essential oil content and composition have proved to be useful in the identifi cation of the parentage of hybrids as they are characteristic for each mint, and the relationships among mints could be deduced from these patterns, although the composition may vary in the course of a year. Based on the monoterpene prevailing in their essential oil, mints have been classifi ed into linalool, menthol, and carvone chemotypes, respectively (Šarić-Kundalić et al., 2009 , and literature cited therein).
According to the available literature, the constituents of the essential oils from M. suaveolens and its different chemotypes have been investigated by gas chromatrography/mass spectroscopy (GC/MS) analysis. The major constituent was either piperitone oxide (Hendriks and Van Os, 1976; Holeman et al., 1985; Oumzil et al., 2002) , piperitenone oxide (Holeman et al., 1985; Oumzil et al., 2002; Koliopoulos et al., 2010; Sutour et al., 2010) , piperitenone (Sutour et al., 2010) , dihydrocarvone (Hendriks and Van Os, 1976) , menthol (Velasco-Negueruela et al., 1996) , pulegone (Velasco-Negueruela et al., 1996; Oumzil et al., 2002; Sutour et al., 2008) , or cis-cis-p-menthenolide (Sutour et al., 2008) .
Few reports were found dealing with the biological activities of the essential oil of M. suaveolens. Oumzil et al. (2002) reported that it had antimicrobial activity, pulegone being the most effective constituent against the tested microorganisms. It also exhibited a fair antibacterial activity (Sutour et al., 2008) . Additionally, acetylcholinesterase (AChE) inhibitory capacity and free radical scavenging activity were reported for the oil (Ferreira et al., 2006) . No information was found in the available literature on the seasonal fl uctuation of the yield and composition of the essential oil of M. suaveolens. Also, the number of reports on the biological activities of the oil is limited. Therefore, it was interesting to study the effect of seasonal variation on the chemical composition of the essential oil from M. suaveolens Ehrh. cultivated in Egypt, in an effort to establish the best conditions for oil production. The essential oil was screened for analgesic, anti-infl ammatory, hepatoprotective, and antioxidant activities. An in vitro study of the antioxidant and cytotoxic activities as well as antimicrobial screening of the essential oil were also carried out. 
Chemical Composition and Biological Activities of the Essential Oil of Mentha suaveolens Ehrh.

Material and Methods
Plant material
Preparation of the essential oil
Samples of fresh aerial parts (1 kg, each) were collected at three-months intervals along four seasons, viz. in January (winter), April (spring), July (summer), and October (autumn). They were subjected to hydrodistillation and the oils obtained dried over anhydrous sodium sulfate. The percentage yields were calculated on a dry weight basis, and the oils were kept in a refrigerator for further analysis. The specifi c gravities and refractive indices were determined according to the Egyptian Pharmacopoeia (CAPA, 1984) procedures. All stated values were the average of three determinations.
GC/MS analysis
The oils were subjected to gas chromato graphy/ mass spectroscopy (GC/MS) analyses on an Agilent (Santa Clara, CA, USA) GC/MS system, model 6890, fi tted with an Agilent mass spectroscopic detector (MSD), model 5937, as well as a 30 m long, cross-linked 5% phenylpolysiloxane fused silica column (HP5-MS capillary column; i.d., 0.25 mm; fi lm thickness, 0.25 μm; Hewlett Packard, Palo Alto, CA, USA). The initial temperature was 60 °C, kept isothermal for 3 min, and then increased to 260 °C at 8 °C; the fi nal temperature was kept isothermal for 15 min. The ion source temperature was 230 °C, and the quadrupole temperature was 150 °C. The carrier gas was helium adjusted at a fl ow rate of 0.1 ml/min. Ionization energy was 70 eV, and scan range was m/z 40 -500 at 3.62 mu/scan.
Identifi cation of the oil components
Library search for identifi cation of the oil components was carried out using a Wiley and Nist (6 th ed.) 275 L GC/MS data base. A series of authentic n-alkanes (C 8 -C 22 ; Poly Science Inc., Niles, MI, USA) was subjected to GLC ana lysis under the same experimental conditions. The retention indices (Kovats indices, KI) of the oil compounds were computed by logarithmic interpolation between bracketing alkanes (Jennings and Shibamoto, 1980) . Identifi cation of the individual compounds was confi rmed by comparison of their retention indices and MS fragmentation patterns with published data (Adams, 2004) .
Analgesic activity
The analgesic activity of the essential oil (summer sample) was evaluated and compared with that of the standard drug indomethacin, using the acetic acid-induced writhing test as described by Koster et al. (1959) . Swiss male albino mice (20 -25 g) were divided into 3 groups each of 6 animals. The fi rst group received 1 ml saline orally and was kept as a negative control. The second group received the essential oil orally in a dose of 100 mg/kg body weight (BW). The last group was orally administered 20 mg/kg BW indomethacin to serve as a positive control. After 30 min, writhing was induced by intraperitoneal injection of 0.6% acetic acid (0.2 ml/mouse). The total number of writhes during a 30-min period starting 5 min after acetic acid injection was counted by placing each mouse in an individual plastic observation chamber.
These, as well as the following in vivo experiments, had been approved by the Offi cial Ethics Committee, National Research Center, Dokki, Giza, Egypt (Ref. E:1 -231), and were conducted according to the Ethics Committee's guidelines.
Acute anti-infl ammatory activity
The acute anti-infl ammatory activity of the essential oil (summer sample) was evaluated and compared with that of the standard indomethacin using the carrageenan-induced rat paw oedema test according to the method of Winter et al. (1962) . Adult male albino rats, weighing 130 -140 g, were divided into 3 groups each of 6 animals. The fi rst group received 1 ml saline orally and was kept as a negative control. The second group was given the essential oil orally in a dose of 100 mg/kg BW. The last group was orally administered 20 mg/kg BW indomethacin and served as a positive control. One h later, infl ammation was induced by subplantar injection of 0.1 ml of 1% carrageenan solution in saline in the right hind paw while 0.1 ml saline was injected in the left hind paw. Four h after oral administration of the tested sample, the rats were euthanized by an overdose of chloroform, both hind paws were excised and separately weighed to calculate the weight of the oedema. The percentage of oedema (infl ammation) was calculated according to the following equation:
% oedema = weight of the right paw -weight of the left paw · 100.
weight of the left paw Furthermore, the percentage of inhibition in the mean of the treated group in comparison with the control non-treated group was estimated and calculated according to the following equation:
% inhibition = paw oedema of control -paw oedema of treated group paw oedema of control · 100.
Antioxidant activity
The in vivo antioxidant activity of the essential oil (summer sample) was investigated by determination of the glutathione (GSH) level in the blood of alloxan-induced diabetic rats according to Beutler et al. (1963) using α-tocopherol (vitamin E) as a standard drug. Adult male albino rats, weighing 130 -140 g, were divided into 4 groups (6 animals per group). The fi rst group was kept as a negative control while diabetes mellitus was induced in the other 3 groups, according to the method described by Eliasson and Samet (1969) , by a single intraperitoneal injection of alloxan (150 mg/kg BW), followed by overnight fasting. Blood samples were obtained from the retro-orbital venous plexus of each rat, and blood glucose levels were measured to confi rm induction of diabetes according to the method of Trinder (1969) using bioMérieux kits. The fi rst group of diabetic rats was kept untreated. The second group was given the essential oil in a dose of 100 mg/kg BW intraperitoneally. The third group was administered 7.5 mg/kg BW vitamin E and served as a positive control. The blood glutathione level was calculated by the following equation:
GSH (mass%) = absorbance of sample · 37.5 · 2.5 · 100. absorbance of standard 1000 0.1
Hepatoprotective activity
The hepatoprotective activity of the essential oil (summer sample) was evaluated by determination of the activities of aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) in the blood of liverdamaged rats. Liver damage in male albino rats (body weight, 100 -130 g) was induced according to the method of Klassan and Plaa (1969) by intraperitoneal injection of 5 ml/kg BW of 25% carbon tetrachloride (CCl 4 ) in liquid paraffi n. Seventy-two h after administration of CCl 4 , blood samples were withdrawn for determination of the enzyme activities. The rats were divided into 3 groups each of 6 animals. The fi rst group of rats received a daily oral dose of 1 ml saline for 7 d before liver damage was induced. Administration of 1 ml saline was continued after induction of liver damage for another 7 d. This group served as a negative control. The second group of the rats was pretreated with a daily oral dose of 100 mg/ kg BW of the essential oil for 7 d. Administration of the essential oil was continued after induction of liver damage for another 7 d. The last group of rats was pretreated with a daily dose (25 mg/kg BW) of silymarin for 7 d before liver damage was induced. Silymarin administration was continued for another 7 d after induction of liver damage. This group served as a positive control. Blood was obtained from the retro-orbital venous plexus through the eye canthus of anaesthetized rats. The levels of AST, ALT (Thewfweld, 1974) , and ALP (Kind and King, 1954) were estimated in blood samples collected from each group at zero time, 7 d after receiving the test sample, 72 h after induction of liver damage, and 7 d after treatment with the test sample.
Free radical scavenging activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay
The free radical scavenging activity of the essential oil (summer sample) was assessed using the DPPH assay according to Takao et al. (1994) as modifi ed by Delazar et al. (2004) . DPPH (4 mg) was dissolved in methanol (50 ml) to obtain a concentration of 80 μg/ml. Serial dilutions of the essential oil were prepared in methanol (20 -400 μg/ml). Diluted solutions (1 ml each) were mixed with equal volumes of DPPH and allowed to stand for 30 min at room temperature. The control sample was prepared by mixing 1 ml of DPPH with 1 ml methanol. The absorbance of each sample was recorded at 517 nm. The experiment was performed in triplicate, and the average absorbance for each concentration was recorded. The same procedure was followed for ascorbic acid and silymarin which were used as positive controls. The IC 50 value was calculated as the concentration (μg/ml) of test sample causing 50% quenching.
Cytotoxicity assay
The cytotoxicity of the essential oil (summer sample) was measured using the sulforhodamine B assay (SRB) (Skehan et al., 1990) on four human carcinoma cell lines: liver (HEPG2), colon (HCT116), larynx (HEP2), and breast (MCF7). The IC 50 (dose which reduces the survival to 50%) values were calculated and compared to those of the reference drug doxorubicin.
Antimicrobial activities
The antimicrobial screening of the essential oil was performed by the agar disc diffusion method (Bauer et al., 1966) . Standard discs impregnated with tetracycline (5 μg/disc) and amphotericin B (5 μg/disc) served as postive controls for antibacterial and antifungal activities, respectively. Filter discs impregnated with 10 μl of dimethyl sulfoxide (DMSO) were used as a negative control. The essential oil was dissolved in DMSO at a concentration of 100 mg/ml. Aliquots of 50 μl (equivalent to 30 μg of the essential oil) were aseptically added to the cups of the inoculated plates. Staphylococcus aureus (ATCC12600), Streptococcus faecalis (ATCC19433), Bacillus subtilis (ATCC6051), Escherichia coli (ATCC11775), Neisseria gonorrhoeae (ATCC19424), Pseudomonas aeruginosa (ATCC10145), Candida albicans (ATCC26555), Saccharomyces cerevisiae (ATCC2180-1A), and Aspergillus niger (Laboratory Collection) were used.
Minimum inhibitory concentrations (the lowest concentration that causes 100% inhibition, MIC 100 ) were determined for Candida albicans, Saccharomyces cerevisiae, and Aspergillus niger using the broth microdilution method (Wu et al., 2003) .
Statistical analysis
The data obtained are presented as means  standard error (S.E.), and the signifi cance of difference between test and control groups was statistically analysed using student's t-test (Snedecor and Cochran, 1982) . P values of 0.05 or less were considered criteria for signifi cance.
Reference drugs and kits
Alloxan, carrageenan, ascorbic acid, doxorubicin, and DPPH were from Sigma (St. Louis, MO, USA), amphotericin B from Bristol-Myers Squibb (Baar, Switzerland), indomethacin from EIPICO Pharmaceutical Co. (6 October City, Egypt), silymarin and tetracycline from Sedico Pharmaceutical Co. (6 October City, Egypt), α-tocopherol from Pharco Pharmaceutical Co. (Alexandria, Egypt), the glutathione kit was from WAK-Chemie Medical (Steinbach, Germany), and transaminase and alkaline phosphatase kits, and blood glucose level kit were from bioMérieux Co. (Craponne, France).
Results and Discussion
The percentage yields of the essential oils obtained by hydrodistillation of the aerial parts of M. suaveolens Ehrh., collected at three-months intervals along the four seasons, were 0.50%, 0.52%, 0.60%, and 0.47% for winter, spring, summer, and autumn samples, respectively, on a dry weight basis. Their specifi c gravities were 0.500, 0.685, 0.615, and 0.517 g/cm 3 at 25 °C, respectively, and refractive indices recorded at 20 °C were 1.491, 1.492, 1.487, and 1.488, respectively. All oil samples exhibited nearly the same physical characters being oily, colourless, with spearmint-like odour, and readily soluble in 70% ethanol.
GC/MS analyses of the samples (Table I) revealed a qualitative and quantitative variability in the oil composition. The overall chromatographic profi le of only the summer sample was dominated by oxygenated compounds, while oil samples from the other seasons were dominated by hydrocarbons. Carvone was the major constituent in the spring, summer, and autumn samples (30.56%, 55.74%, and 34.80%, respectively), while limonene (25.98%) was the major constituent of the winter sample followed by carvone (24.72%). Limonene was the only monoterpene hydrocarbon detected in winter, spring, and summer samples. It was the major component in the autumn sample. The major sesquiterpene hydrocarbon in winter, spring, and summer samples was trans-β-caryophyllene (7.84%, 8.51%, and 2.72%, respectively) while in the autumn sample, it was β-bourbonene (5.18%). The highest percentage of esters was in the winter sample among which dihydrocarveol acetate (9.98%) was the major constituent. The proportions of the compounds of the essential oils changed somewhat with the seasons; however, there was no signifi cant difference in the content of the main component, carvone. Previous investigations of the chemical composition of the essential oil from M. suaveolens from different populations and various geographical regions showed that the plants belong either to the menthol or carvone chemotype (Šarić-Kundalić et al., 2009 , and literature cited therein). The production of piperitenone, piperitone oxide, piperitenone oxide, menthol, and pulegone follows the menthol pathway (Hendriks and Van Os, 1976; Holeman et al., 1985; Velasco-Negueruela et al., 1996; Oumzil et al., 2002; Sutour et al., 2008 Sutour et al., , 2010 Koliopoulos et al., 2010) . Carvone, dihydrocarvone, and carveol characterize the carvone pathway (Hendriks Van Os, 1976; Šarić-Kundalić et al., 2009; Kumar et al., 2011) . M. suaveolens Ehrh. cultivated in Egypt can be categorized as the carvone chemotype since this compound was a major constituent throughout the seasons.
The essential oil obtained in the highest yield (full-fl owering summer sample), and having the highest contents of oxygenated constituents and carvone, was screened for a number of biological activities. It exhibited analgesic and acute anti-infl ammatory activities [75.0% and 81.6% relative to a standard dose (20 mg/kg BW) of indomethacin] (Tables II and III) .
The essential oil exerted a potent in vivo antioxidant activity (95.8% relative to α-tocopherol) ( Table IV) . The in vitro antioxidant (free radical scavenging) activity of the essential oil had an IC 50 value of 200 μg/ml, in comparison to silymarin (45 μg/ml) and ascorbic acid (7.5 μg/ml).
The essential oil prevented the increase in the blood levels of AST, ALT, and ALP by 56.8%, 52.6%, and 53.5%, respectively (Table V) . This protective effect was comparable to that of silymarin which prevented the rise in the level of these enzymes by 64.1%, 60.9% and 76.0%, respectively. Furthermore, administration of the essential oil for another 7 days after induction of liver damage led to a signifi cant decrease in the enzyme levels which indicates stabilization of hepatocyte cell membranes and repair of liver damage caused by CCl 4 (Singab et al., 2005) . Since prevention of CCl 4 -induced liver damage is considered indicative of general hepatoprotective activity of a drug (Wu and Norton, 1996) , the present study has established that the essential oil of M. suaveolens holds promise for nutritional and pharmaceutical applications. As established by the American National Cancer Institute (NCI), a crude extract is considered cytotoxic when the IC 50 value in the preliminary assay of Suffness and Pezzuto (1990) is less than 30 μg/ ml. In this respect, the essential oil of M. suaveolens could be considered moderately cytotoxic (IC 50 = 10.60, 14.00, 9.15, and 18 .20 μg/ml in liver, colon, larynx, and breast carcinoma cell lines, respectively) as compared to doxorubicin (IC 50 = 3.73, 3.73, 3.73, and 2.97 μg/ml, respectively) . The antimicrobial activity of the essential oil in the agar disc diffusion assay was moderate against bacteria and very potent against fungi (Table VI) . Therefore, the minimum inhibitory concentration (MIC) was determined for the fungi in the broth microdilution assay. The essential oil exhibited a broadspectrum potent antifungal activity against Candida albicans (MIC = 4 μg/ml), Saccharomyces cerevisiae (MIC = 5.2 μg/ml), and Aspergillus niger (MIC = 6.8 μg/ ml). A correlation between the inhibition zone diameter in the agar disc diffusion assay and MIC values in the broth microdilution assay was found. Candida albicans showed the maximum zone of inhibition and the minimum MIC value followed by Saccharomyces cerevisiae and Asperigillus niger. Previous results of an investigation of antifungal properties had shown that monoterpene hydrocarbons had lower antifungal activity than oxygenated terpenes (Soković et al., 2009) . Hydrocarbons tend to be relatively inactive regardless of their structural type, and this inactivity is closely related to their limited hydrogen binding capacity and water solubility (Soković et al., 2009) . The higher antifungal, as compared to antibacterial, potential of the essential oil of M. suaveolens could be explained by the presence of carvone, which possesses a very strong antifungal activity (Soković et al., 2009) . These results indicate that the essential oil may be used as a natural preservative in food against the well known causal agents of food-borne diseases and food spoilage, after conducting the necessary in vivo toxicity studies. 
Conclusion
From the economical point of view, the aerial parts of M. suaveolens Ehrh. should preferably be collected in summer from plants cultivated in Egypt, when the highest yield of the oil is obtained. Moreover, the essential oil from such plant material has the highest percentage of oxygenated constituents and the highest carvone content. M. suaveolens Ehrh. cultivated in Egypt can be categorized as carvone-rich type, since this compound has a high relative level throughout the seasons. The different biological activities evaluated for the essential oil revealed signifi cant effi cacy and potency when compared to standard drugs. This suggests the incorporation of the oil in herbal formulations after necessary clinical trials. 
